Femasys (FEMY) Cash & Equivalents Growth (1y) (2021 - 2026)
Femasys (FEMY) Cash & Equivalents Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -23.33% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 21.89% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 78.03% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 29.00% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 19.45% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 21.40% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.94% |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - | 40.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40.99% |
| Dec 31, 2025 | 168.45% |
| Sep 30, 2025 | -39.97% |
| Jun 30, 2025 | -76.21% |
| Mar 31, 2025 | -78.58% |
| Dec 31, 2024 | -84.11% |
| Sep 30, 2024 | -12.44% |
| Jun 30, 2024 | 26.35% |
| Mar 31, 2024 | 75.53% |
| Dec 31, 2023 | 67.54% |
| Sep 30, 2023 | -45.69% |
| Jun 30, 2023 | -44.00% |
| Mar 31, 2023 | -53.32% |
| Dec 31, 2022 | -47.70% |
| Sep 30, 2022 | -41.33% |
| Jun 30, 2022 | -35.98% |
| Dec 31, 2021 | 645.98% |